Clinical Trials Insight: 700032115

Trial Profile

Clinical Trials Insight: 700032115

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Jun 2010

At a glance

  • Drugs MBX 2982 (Primary)
  • Indications Type 2 diabetes mellitus; Various toxicities
  • Focus Adverse reactions
  • Sponsors Metabolex
  • Most Recent Events

    • 22 Jun 2010 Status changed from recruiting to completed, as reported in a Metabolex media release.
    • 02 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top